Prevention of osteoporosis can be facilitated by all of the following: Multiple options may be correct

A. Vitamin E: Vitamin E is an antioxidant that supports general cellular health but does not play a direct role in bone mineralization or prevention of bone loss. It is not recommended as a primary intervention for osteoporosis prevention. B. Ibandronate: Ibandronate is a bisphosphonate that inhibits osteoclast-mediated bone resorption, helping to maintain or increase bone density. It is commonly prescribed for both prevention and treatment of osteoporosis, especially in postmenopausal individuals. C. Calcium: Calcium is a key mineral required for bone formation and maintenance of bone density. Adequate intake helps prevent bone demineralization and reduces the risk of fractures associated with osteoporosis. D. Vitamin C: Vitamin C supports collagen formation, which is important for connective tissue, but it is not a primary factor in bone mineral density. Its role in osteoporosis prevention is supportive rather than direct. E. Phosphorus: Phosphorus works closely with calcium to form hydroxyapatite crystals, which provide structural strength to bones. Adequate phosphorus intake contributes to proper bone mineralization. F. Magnesium: Magnesium is involved in bone formation and influences the activity of osteoblasts and osteoclasts. It also helps regulate calcium and vitamin D metabolism, making it important in maintaining bone health. G. Glucosamine: Glucosamine is commonly used for joint health and osteoarthritis, supporting cartilage rather than bone density. It does not have a significant role in preventing osteoporosis. H. Vitamin D: Vitamin D enhances intestinal absorption of calcium and phosphorus, which are essential for bone mineralization. Deficiency can lead to decreased bone density and increased fracture risk.